Broomfield Hospital is an acute district general hospital in Chelmsford, Essex. It is managed by the Mid and South Essex NHS Foundation Trust.

There are 800 beds in Broomfield Hospital.

During the past decade, Broomfield Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 19 clinical trials were completed, i.e. on average, 105.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 12 clinical trials were completed. i.e. 1200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Broomfield Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "University College, London" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Broomfield Hospital" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "University of Birmingham" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Broomfield Hospital" are "Breast Cancer" (12 trials), "Gastroparesis" (4 trials), "Colorectal Cancer" (3 trials), "Diabetes Mellitus" (3 trials) and "Fallopian Tube Cancer" (3 trials). Many other conditions were trialed in "Broomfield Hospital" in a lesser frequency.

Most popular intervention types in "Broomfield Hospital" are "Drug" (45 trials), "Procedure" (12 trials), "Other" (6 trials), "Biological" (5 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "adjuvant therapy" (7 trials), "carboplatin" (4 trials), "cyclophosphamide" (4 trials) and "Relamorelin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Broomfield Hospital" are 47 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Broomfield Hospital". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Broomfield Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Broomfield Hospital, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".